Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder

Wednesday, November 22, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses the FDA clearance of the H7 Coil for treating treatment-refractory Obsessive-Compulsive Disorder (OCD), supported by results from two randomized controlled trials (RCTs). Additionally, the D-B80 and iron-core figure-8 coils received 510K clearance, highlighting advancements in transcranial magnetic stimulation technology. The physical properties of these coils differ, potentially affecting their functional applications.
Price reaction · baseline $2.49 (2023-11-21 close) · hit pre-market · 16 other BWAY headline(s) in the window, move may be shared
day 0 close
+10.6%
day 1
+17.1%
day 3 · peak
+23.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA clearance for H7 Coil indicates regulatory confidence.
  • Results from two RCTs support its efficacy in OCD treatment.
  • New coil designs may enhance treatment options for patients.

Full Press Release Details

Key Points:

• Converging lines of evidence suggest that OCD involves dysfunction of limbic cortico-striato-thalamo-cortico loops including the orbitofrontal cortex, medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC).
• The H7 Coil was FDA-cleared for treatment-refractory OCD based on results of two RCTs. Subsequently, a 510K clearance was granted to the D-B80 and iron-core figure-8 coils.
• The physical properties of these coils differ from the H7 Coil, resulting in different functional properties.
Converging lines of evidence suggest that OCD involves dysfunction of limbic cortico-striato-thalamo-cortico loops including the orbitofrontal cortex, medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC).
The H7 Coil was FDA-cleared for treatment-refractory OCD based on results of two RCTs. Subsequently, a 510K clearance was granted to the D-B80 and iron-core figure-8 coils.
Full Article:
https://www.sciencedirect.com/science/article/abs/pii/S0193953X22000818?via%3Dihub

Frequently Asked Questions

What is the H7 Coil used for?

The H7 Coil is used for treating treatment-refractory Obsessive-Compulsive Disorder (OCD).

What evidence supports the use of the H7 Coil?

The H7 Coil's FDA clearance is based on results from two randomized controlled trials.

What other coils received FDA clearance?

The D-B80 and iron-core figure-8 coils also received 510K clearance.

How do the coils differ from each other?

The physical properties of the coils differ, resulting in varying functional properties.

ShareAdd on Google
Tags: BWAY Viatris Investor Conferences Healthcare H7 Coil D-B80 OCD FDA clearance transcranial magnetic stimulation
Last updated: Nov 22, 2023

Biotech snapshot

Lead asset
SIR2501Phase 2
Chemotherapy-induced Peripheral Neuropathy →